We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-20.46%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.64B
AUM Growth
+$440M
Cap. Flow
+$940M
Cap. Flow %
57.18%
Top 10 Hldgs %
44.47%
Holding
4,515
New
888
Increased
1,264
Reduced
882
Closed
1,360

Sector Composition

Rank Sector Weight
1 Financials 4.56%
2 Industrials 3.56%
3 Consumer Discretionary 3.21%
4 Technology 3.1%
5 Healthcare 2.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRS icon
3851
STRATUS PPTYS INC
STRS
-94
Closed -$3K
STZ icon
3852
Constellation Brands
STZ
$22.5B
-294
Closed -$56K
SUSA icon
3853
iShares ESG Optimized MSCI USA ETF
SUSA
$4.17B
-1,838
Closed -$123K
SUSL icon
3854
iShares ESG MSCI USA Leaders ETF
SUSL
$1.22B
-2,917
Closed -$162K
SVXY icon
3855
ProShares Short VIX Short-Term Futures ETF
SVXY
$230M
-235,990
Closed -$7.7M
SWBI icon
3856
Smith & Wesson
SWBI
$640M
-40
Closed
SWKS icon
3857
Skyworks Solutions
SWKS
$10.5B
-1,745
Closed -$211K
SXI icon
3858
Standex International
SXI
$4.03B
-100
Closed -$8K
SYRE icon
3859
Spyre Therapeutics
SYRE
$8.94B
-292
Closed -$56K
TAC icon
3860
TransAlta
TAC
$3.94B
-4,161
Closed -$29K
TAK icon
3861
Takeda Pharmaceutical
TAK
$56B
$0 ﹤0.01%
15
-10,396
-100% -$188K
TAP.A icon
3862
Molson Coors Class A
TAP.A
$0 ﹤0.01%
+8
New +$481
TATT icon
3863
TAT Technologies
TATT
$485M
-168
Closed -$1K
TAYD icon
3864
Taylor Devices
TAYD
$169M
$0 ﹤0.01%
41
-110
-73% -$1.2K
TBI
3865
Trueblue
TBI
$320M
-1,848
Closed -$44K
TBPH icon
3866
Theravance Biopharma
TBPH
$877M
-3,094
Closed -$80K
TCBK icon
3867
TriCo Bancshares
TCBK
$1.83B
-48
Closed -$2K
TCMD icon
3868
Tactile Systems Technology
TCMD
$540M
-199
Closed -$13K
TEAF
3869
DELISTED
Ecofin Sustainable & Social Impact Term Fund
TEAF
-1,200
Closed -$20K
TEO icon
3870
Telecom Argentina
TEO
$6.18B
-906
Closed -$10K
TGI
3871
DELISTED
Triumph Group
TGI
-6,326
Closed -$160K
TGTX icon
3872
TG Therapeutics
TGTX
$7.65B
-100
Closed -$1K
TH icon
3873
Target Hospitality
TH
$1.69B
-610
Closed -$3K
THM
3874
International Tower Hill Mines
THM
$709M
$0 ﹤0.01%
300
THR
3875
DELISTED
Thermon Group Holdings
THR
-50
Closed -$1K

Similar funds

Tower Research Capital (TRC)'s Q1 2020 Portfolio in Review

As of Q1 2020, Tower Research Capital (TRC) held 4,515 positions worth $1.64B, up 37% from $1.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Tower Research Capital (TRC) deployed $940M of net new capital in Q1 2020, opening 888 new positions and adding to 1,264 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 161,566 shares worth $38.3M.

By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 2.5% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $87.2M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2020 buy was Vanguard S&P 500 ETF: 161,566 shares worth $38.3M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $101M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $87.2M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q1 2020, selling an estimated $19.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 44% of its $1.64B portfolio in Q1 2020.
  • Tower Research Capital (TRC) opened 888 new positions and closed 1,360 in Q1 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.64B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2020, filed 15 May 2020.